AI screening for pancreatic cancer in higher-risk people
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent (or your legal representative can) and are willing to join the study
- You’re willing to complete a detailed questionnaire
- You fit at least one high-risk group: new diabetes in the last 3 years, family history of pancreatic cancer, inherited cancer-related conditions, certain pancreatic cysts, or chronic pancreatitis
- You do not have pancreatic cancer (or another cancer) diagnosed within the past 5 years
- You can safely get high-resolution MRI or CT (no contraindications) and you can attend follow-ups; you’re not in another conflicting clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze routine CT scans of the chest or abdomen (done for other reasons) to detect early signs of pancreatic cancer. If you are already getting a CT scan for another health issue, this could help catch pancreatic cancer early without extra tests.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This study uses artificial intelligence to analyze low-dose CT scans of the abdomen to detect early signs of pancreatic cancer. It may help find cancer before symptoms appear.
This study is using an artificial intelligence tool called 'PANDA' to look at your existing CT scans to help find or evaluate pancreas conditions. It might help detect problems earlier, so your doctor can act sooner.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.